Medpace Holdings (FRA:01P) Total Stockholders Equity : €549 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Total Stockholders Equity?

Medpace Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €549 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Medpace Holdings's Book Value per Share for the quarter that ended in Mar. 2025 was €18.40. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Medpace Holdings's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.21.

Medpace Holdings Total Stockholders Equity Historical Data

The historical data trend for Medpace Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Total Stockholders Equity Chart

Medpace Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

662.35

843.34

364.75

512.56

788.40

Medpace Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															617.82	709.38	794.18	788.40	549.09

Medpace Holdings (FRA:01P) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Medpace Holdings's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(549.088	-	0)	/	29.836
	=	18.40

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Medpace Holdings's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	117.16)	/	549.088
	=	0.21

Medpace Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MEDP:USA MEDP:Mexico 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Medpace Holdings Headlines

No Headlines